About Us

Our
Vision

To be the
catalyst that
sparked a cure
for cancer.

Our Mission

We identify, develop, and sustain emerging talent in oncology in the Tri-state area with a focus on funding translational and collaborative research projects that evolve into novel interventions for the prevention and treatment of cancer.

We scout out and fund the most promising emerging talent at the beginning of their careers and support them for the time it takes for their ideas to translate from a spark to real breakthrough. At our best, we can change lives for the better – the lives of patients, the researchers we fund, and our donors – all of whom come together to transform patients’ cancer journeys for the better. Our legacy of success since 1968 continues to grow, powered by the community that has expanded to encompass 11 research institutions.

Our Leadership

Science is the solution

My mother lived with ovarian cancer for almost ten years thanks to her oncologist, Dr. Franco M. Muggia. It could have been a death sentence. Instead, we had almost 10 more birthdays and holidays together. And she had time to see a future – one with children and grandchildren, challenges, and laughter. She had life. It was through Franco that I became involved with The Chemotherapy+ Foundation.

Michael G. Rosenberg Chair,
Board of Trustees

Invest in emerging talent

I’m a good example of how The Chemotherapy+ Foundation community works – find talent early and nurture it. Early in my career, the Foundation saw promise in my research and invited me to participate in a symposium. I later became a member of the Medical Advisory Council. From there, I moved up to serving on the Board of Trustees. Now I am the Chair of the Medical Advisory Council.

William K. Oh, MD Chair,
Medical Advisory Council

Research leads to longer, better lives

When I was asked to join this organization as executive director, I could not say no. My work is all about the art of science. My days are filled with conversations about new studies and the latest breakthroughs. I talk to patients who have gone into remission, are in treatment or are at the beginning of their cancer journey. For a research- focused organization, we balance the scientific with the personal. And I’m making a difference in people’s lives.

Paola G. Muggia
Executive Director

Board of Trustees

Michael G. Rosenberg, Chair

President and CEO PIM Brands

William K. Oh, M.D.

Chair of the Medical Advisory Council, Chief Medical Officer, The Prostate Cancer Foundation, Clinical Professor of Medicine, Mount Sinai

Craig J. Goldberg, Treasurer

Managing Partner, Synterra Capital Management LLC

Peter Alkalay, Esq.

Partner, McLaughlin & Stern, LLP

Talia Biran President

Oncolys USA

Suzanne M. Miller, Ph.D.

Professor, Senior Member, Cancer Prevention and Control Director, Patient Empowerment and Decision Making Fox Chase Cancer Center/Temple University Health System

Eric S. Richter

Senior Vice President – Investments Stifel, Nicolaus & Company, Inc.

Peter G. DeMaria, CFA

Corporate Development Officer, PIM Brands

Medical Advisory Council

Stephanie Blank, MD

Director of Gynecologic Oncology for the Mount Sinai Health System Director of Women’s Health The Blavatnik Family – Chelsea Medical Center at Mount Sinai Professor, Obstetrics, Gynecology, and Reproductive Science

Delong Liu, MD

Professor of Medicine, Hematologist and Oncologist, Westchester Medical Center

Silvia Chiari Formenti, M.D.

Professor and Chair of Radiation Oncology and Radiation Oncologist-in-Chief, Weill Cornell School of Medicine/NY Presbyterian/Weill Cornell Medical Center

Roy Herbst, MD

Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Director, Center for Thoracic Cancers; Deputy Director, Clinical Affairs; Assistant Dean for Translational Research, Office of the Dean, School of Medicine; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; Associate Cancer Center Director, Translational Science

Howard S. Hochster, M.D

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers-CINJ Associate Director, Clinical Research Director Clinical Oncology Research

Steven H. Itzkowitz, M.D.

Director of GI Fellowship Program Division of Gastroenterology Icahn School of Medicine at Mount Sinai

Larry Norton, MD

Senior Vice President, Office of the President; Medical Director, Evelyn H. Lauder Breast Center; Norna S. Sarofim Chair in Clinical Oncology

Joseph Sparano

Chief of Hematology and Medical Oncology Deputy Director of The Tisch Cancer Institute Ezra M. Greenspan, MD Professorship in Clinical Cancer Therapeutics Icahn School of Medicine at Mount Sinai Mount Sinai Health System

Cora Sternberg, MD

Professor of Medicine and the Clinical Director of the Englander Institute for Precision Medicine, Weill

Young Leadership
Board

Marc Rosenberg, Chairman
Kristina Antipin
Alexandra Forman
Sarah Grubman
Leonard Licht, Esq.
Brandon Masterson
Morgan McCarthy
Samuel Meyers
Eric Pittel
Lexie Reiffman
Jonathan Rosenberg
Lauren Rosenberg
Jay Shi
Emily Silverman

Honorary Trustees

Sheila Cornstein
Lorraine Machiz
Marvin Scott, Senior Correspondent, WPIX Channel 11 News
Jane Gural Senders
Howard Silverman
Barbara Zwicker

Our Historic Leaders

Founded to drive innovation and new therapies

Dr. Ezra Greenspan founded The Chemotherapy Foundation in 1968 to drive innovation and new therapies in the new field of Oncology.

Defining the future of cancer care

Mr. Barry Richter was Trustee, President and Chief Executive Officer of The Foundation for more than 35 years. Under his leadership, The Foundation expanded the scope of the research and educational programs.

Research impacts all areas of Oncology

Dr. Franco Muggia was a talented and visionary oncologist with the ability to bring oncologists, from different institutions, together to share the latest in clinical trials and treatments.